Shared genetic etiology between Parkinson’s disease and blood levels of specific lipids

Abstract Parkinson’s disease (PD) is characterized by the degeneration of dopaminergic neurons in the substantia nigra and the formation of Lewy bodies. The mechanisms underlying these molecular and cellular effects are largely unknown. Previously, based on genetic and other data, we built a molecul...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Helena Xicoy, Cornelius JHM Klemann, Ward De Witte, Marijn B Martens, Gerard JM Martens, Geert Poelmans
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/e240c660e8524bc1a0cfe4a057c8995d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e240c660e8524bc1a0cfe4a057c8995d
record_format dspace
spelling oai:doaj.org-article:e240c660e8524bc1a0cfe4a057c8995d2021-12-02T13:34:53ZShared genetic etiology between Parkinson’s disease and blood levels of specific lipids10.1038/s41531-021-00168-92373-8057https://doaj.org/article/e240c660e8524bc1a0cfe4a057c8995d2021-03-01T00:00:00Zhttps://doi.org/10.1038/s41531-021-00168-9https://doaj.org/toc/2373-8057Abstract Parkinson’s disease (PD) is characterized by the degeneration of dopaminergic neurons in the substantia nigra and the formation of Lewy bodies. The mechanisms underlying these molecular and cellular effects are largely unknown. Previously, based on genetic and other data, we built a molecular landscape of PD that highlighted a central role for lipids. To explore which lipid species may be involved in PD pathology, we used published genome-wide association study (GWAS) data to conduct polygenic risk score-based analyses to examine putative genetic sharing between PD and blood levels of 370 lipid species and lipid-related molecules. We found a shared genetic etiology between PD and blood levels of 25 lipids. We then used data from a much-extended GWAS of PD to try and corroborate our findings. Across both analyses, we found genetic overlap between PD and blood levels of eight lipid species, namely two polyunsaturated fatty acids (PUFA 20:3n3-n6 and 20:4n6), four triacylglycerols (TAG 44:1, 46:1, 46:2, and 48:0), phosphatidylcholine aa 32:3 (PC aa 32:3) and sphingomyelin 26:0 (SM 26:0). Analysis of the concordance—the agreement in genetic variant effect directions across two traits—revealed a significant negative concordance between PD and blood levels of the four triacylglycerols and PC aa 32:3 and a positive concordance between PD and blood levels of both PUFA and SM 26:0. Taken together, our analyses imply that genetic variants associated with PD modulate blood levels of a specific set of lipid species supporting a key role of these lipids in PD etiology.Helena XicoyCornelius JHM KlemannWard De WitteMarijn B MartensGerard JM MartensGeert PoelmansNature PortfolioarticleNeurology. Diseases of the nervous systemRC346-429ENnpj Parkinson's Disease, Vol 7, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Neurology. Diseases of the nervous system
RC346-429
spellingShingle Neurology. Diseases of the nervous system
RC346-429
Helena Xicoy
Cornelius JHM Klemann
Ward De Witte
Marijn B Martens
Gerard JM Martens
Geert Poelmans
Shared genetic etiology between Parkinson’s disease and blood levels of specific lipids
description Abstract Parkinson’s disease (PD) is characterized by the degeneration of dopaminergic neurons in the substantia nigra and the formation of Lewy bodies. The mechanisms underlying these molecular and cellular effects are largely unknown. Previously, based on genetic and other data, we built a molecular landscape of PD that highlighted a central role for lipids. To explore which lipid species may be involved in PD pathology, we used published genome-wide association study (GWAS) data to conduct polygenic risk score-based analyses to examine putative genetic sharing between PD and blood levels of 370 lipid species and lipid-related molecules. We found a shared genetic etiology between PD and blood levels of 25 lipids. We then used data from a much-extended GWAS of PD to try and corroborate our findings. Across both analyses, we found genetic overlap between PD and blood levels of eight lipid species, namely two polyunsaturated fatty acids (PUFA 20:3n3-n6 and 20:4n6), four triacylglycerols (TAG 44:1, 46:1, 46:2, and 48:0), phosphatidylcholine aa 32:3 (PC aa 32:3) and sphingomyelin 26:0 (SM 26:0). Analysis of the concordance—the agreement in genetic variant effect directions across two traits—revealed a significant negative concordance between PD and blood levels of the four triacylglycerols and PC aa 32:3 and a positive concordance between PD and blood levels of both PUFA and SM 26:0. Taken together, our analyses imply that genetic variants associated with PD modulate blood levels of a specific set of lipid species supporting a key role of these lipids in PD etiology.
format article
author Helena Xicoy
Cornelius JHM Klemann
Ward De Witte
Marijn B Martens
Gerard JM Martens
Geert Poelmans
author_facet Helena Xicoy
Cornelius JHM Klemann
Ward De Witte
Marijn B Martens
Gerard JM Martens
Geert Poelmans
author_sort Helena Xicoy
title Shared genetic etiology between Parkinson’s disease and blood levels of specific lipids
title_short Shared genetic etiology between Parkinson’s disease and blood levels of specific lipids
title_full Shared genetic etiology between Parkinson’s disease and blood levels of specific lipids
title_fullStr Shared genetic etiology between Parkinson’s disease and blood levels of specific lipids
title_full_unstemmed Shared genetic etiology between Parkinson’s disease and blood levels of specific lipids
title_sort shared genetic etiology between parkinson’s disease and blood levels of specific lipids
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/e240c660e8524bc1a0cfe4a057c8995d
work_keys_str_mv AT helenaxicoy sharedgeneticetiologybetweenparkinsonsdiseaseandbloodlevelsofspecificlipids
AT corneliusjhmklemann sharedgeneticetiologybetweenparkinsonsdiseaseandbloodlevelsofspecificlipids
AT warddewitte sharedgeneticetiologybetweenparkinsonsdiseaseandbloodlevelsofspecificlipids
AT marijnbmartens sharedgeneticetiologybetweenparkinsonsdiseaseandbloodlevelsofspecificlipids
AT gerardjmmartens sharedgeneticetiologybetweenparkinsonsdiseaseandbloodlevelsofspecificlipids
AT geertpoelmans sharedgeneticetiologybetweenparkinsonsdiseaseandbloodlevelsofspecificlipids
_version_ 1718392766341316608